Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice

Abstract

Hydrogen sulfide (H 2 S) is increasingly recognized as a gasotransmitter with protective effects in the cardiovascular system. The aim of the study was to examine the effects of chronic NaHS treatment on blood pressure, vascular function and oxidative stress in an in vivo model of hypertension and oxidative stress. Male C57Bl6/J mice were rendered hypertensive with 0.7 mg kg -1 per day angiotensin II (AngII) for 14 days administered via implanted mini-pumps. The mice were treated with NaHS (10 μmol kg -1 per day) to deliver H 2 S or an inhibitor of cystathionine-γ-lyase, DL-propargylglycine (PPG 30 mg kg -1 per day) via intraperitoneal (i.p.) injection. Systolic blood pressure was measured and vascular function examined by myography. Vascular superoxide production was measured by lucigenin-enhanced chemiluminescence. AngII infusion significantly increased systolic blood pressure (P<0.001). This increase was significantly attenuated by treatment with NaHS (P<0.001). Both aortic endothelial function and NO bioavailability were significantly attenuated in the AngII group (P<0.01) but this attenuation was reversed by NaHS treatment. Similarly, aortic superoxide anion production was significantly enhanced by AngII (P<0.01), and this was reversed by NaHS treatment, and also exacerbated by PPG treatment (P<0.001). These data show that in a mouse model of hypertension and oxidative stress induced by AngII, exogenous H 2 S treatment in vivo reduces blood pressure, endothelial dysfunction and vascular oxidative stress, while inhibiting endogenous H 2 S production in vivo is deleterious. This furthers the evidence that H 2 S is a vasoprotective molecule that may be a useful treatment target in cardiovascular disease.